INTRODUCTION
============

Cordyceps, an entomogenous fungus formed from larvae and pupae of insects, are regarded as human health supplement or potential drugs for their beneficial effects such as anti-tumorigenicity, immunostimulation, hypoglycemic effects and decreased production of peroxisome [@B018]; [@B014]; [@B027].

Especially, cordyceps formed from silk worms larvae have been used as a traditional folk remedy or food ingredient to strengthen the immune function and regain vitality in Asian countries including China, Japan and Korea [@B012].

*Paecilomyces sinclairiis*, a new kind of *Cordyceps*spp., isolated from cicada larvae has been successfully mass produced through artificial cultivation from silk worm larvae after infected with *Paecilomyces sinclairiis* [@B016]; [@B028].

Many studies regarding PS toxicity were performed but there are limited numbers of studies for toxicity of PS only. When adult SD rats were administered orally with the complex powder suspension of *Paecilomyces sinclairii* with its host *Bommbyx mori*larvae at doses from 0.008 g/kg bw to 5 g/kg bw for 2 weeks, any toxicological effects were not observed excepting reduced weights of thymus in males [@B019]. Single oral toxicity study of the complex showed that doses showing 50% lethality (LD50) were above 5\~10 g/kg bw in rats and dogs, which means it is practically non-toxic material [@B015]. The complex did not induce any genotoxic effects in a battery of tests; bacterial reverse mutation assay, mammalian cell chromosome aberration assay and rodent micronucleus assay [@B004]. However, histopathological lesions of kidney were manifested when the complex of fruiting body of *Paecilomyces sinclairii* and silk worm larvae were provided via feed for 13 weeks [@B003]. The lesions were tubular destruction, tubular edema and tubular cell abnormalities.

In another study, cordyceps mushrooms have been reported to support kidney functions via increase of 17- hydroxy-corticosteroid and 17-ketosteroid levels [@B034]. So, it is required to elucidate whether PS is beneficial or toxic to kidney functions and the dose of effects if it is a nephrotoxic material.

Kidney histopathology and biochemistry markers such as serum creatinine and BUN have been commonly used for the evaluation of nephrotoxicity of chemicals and bio-materials. However, these indicators show changes only when significant degree of renal functions is damaged [@B025]. So, the indicators have been skeptical as markers of prediction and diagnosis for kidney damage.

Recently, USA FDA and European Medicines Agency have validated seven urinary renal biomarkers, KIM-1, albumin, clusterin, trefoil factor 3 (TFF3), total protein, cystatin C and β2m for monitoring nephrotoxicity in preclinical toxicity test, which biomarkers were proposed by the Predictive Safety Testing Consortium's Nephrotoxicity Working Group [@B006].

[@B033] suggested a number of novel biomarkers including KIM-1, NGAL, α-GST, glutathione S-transferase- yb1 (GST-Yb1) and Pap X Clone 5C10 (RPA-1) for the detection of acute kidney injury, which are more sensitive than traditional biomarkers, BUN and serum creatinine. These biomarkers have been proposed as sensitive and specific markers of site-specific renal tubular injury following ischemia, necrosis or glomerular filtration dysfunction by renal toxicants [@B009].

The objective of the present study was to determine whether the PS induce kidney toxicity or not, by using sensitive novel biomarkers of kidney damage.

MATERIALS AND METHODS
=====================

***Animals.*** Specific pathogen-free 5-week-old male and female Sprague Dawley (SD) rats were purchased from a commercial animal breeder (Hanrim Lab animal Institute, Gyeongido, Korea). Each fifty male and female rats were acclimated for 1 week in environmentally controlled room at 22 ± 2℃, 50 ± 10% humidity, air ventilation of 10\~15 times/hr and a 12 h light/dark cycle, and were provided commercial pellets (Purina Co., Korea) and UV-sterilized and filtered tap water *ad libitum*.

The animal experiments were conducted in accordance with the Ethics for the Care and Use of Laboratory Animals prepared by Hoseo Toxicological Research Center of Hoseo University.

***Materials.*** *Paecilomyces sinclairii* endophytically parasitizing dead or living *Cicadae*subspecies was isolated from conidiospores and cultured in potato dextrose agar medium and then inoculated onto silkworms (Rural Development Administration, KOREA). The fruiting bodies of *Paecilomyces sinclairii* was collected and then dried and homogenized to be a powder-form. Each amount of the powder of the complex was mixed with feed powder (Rat and Mouse 18% 5L79, PMI Nutrition International, MO, USA) at 5,000 ppm, 10,000 ppm and 50,000 ppm. The mixture was knead by adding distilled water and then made into pellet feed by drying at temperature 57℃.

***Treatments.***Forty SD male and female rats each were randomly divided into four groups (Control, 5,000, 10,000 and 50,000 ppm) of ten animals each dose group and sex. Further 10 males and females each were allocated into control and the highest group to see recovery of any toxic effects at 2 weeks post-exposure. Control group was provided with normal feed without addition of the powder complex of PS. Male and female rats were administered with PS at 0, 5,000, 10,000 and 50,000 ppm via feeding for 13 weeks.

After 13 weeks of treatment or further 2 weeks postexposure, animals were anesthetized and blood was collected via abdominal artery. Serum samples were collected by centrifugation at 13,000 ×g for 15 min and supernatants were stored at −80℃ until analysis.

Kidneys were taken out and weighed. Half of vertical and horizontal sections of each kidney were fixed in formalin for histopathological examination. Remained parts were weighed on a milligram scale and then transferred to 25 μ*l* of lysis buffer 500 mM NaH~2~PO~4~/Na~2~HPO~4~ buffer and 0.1% tween 20 in H~2~O with protease inhibitor cocktail (Roche, Germany) per mg of wet weight tissue. The tissue was ground using a motor glass-teflon homogenizer (DaiHan Scientific Co., Ltd., Korea) with 7 strokes on ice and centrifuged at 16,000 ×g for 15 min at 4℃. The supernatant was collected and stored at ?20℃ until analysis.

On days 13, 55, 90 of treatment and day 13 of recovery, the rats were transferred to individual metabolic cages and 24-hour urine was collected on ice in 50 m*l* polypropylene tubes containing 1 m*l* 1% sodium azide. The urine was measured in volume and stored at −80℃ until analysis.

***Serum biochemistry analysis.*** BUN and creatinine in serum were measured using clinical chemistry analyzer (HITACHI 7020) using each assay kit.

***Kidney damage biomarkers determination.*** Serum, kidney tissue homogenates and urine samples were analyzed for KIM-1, TIMP-1, VEGF, osteopontin, clusterin, NGAL, β2m, GST-α, calbindin, and cystatin C using commercially available rat multiplex immunoassay kits (Merck KGaA Darmstadt, Germany) on the multiplex flow cytometry (Luminex xMAP system).

***Statistical analysis.*** Data are expressed as mean ± SD. Statistical significance between the control and treated groups were determined by one-way analysis of variance (ANOVA) followed by Duncan's multiple tests using the STATISTICA program. A difference in the mean values of *p* \< 0.05 was considered to be statistically significant.

RESULTS
=======

***The changes of kidney weight.*** The absolute and relative kidney weights were not different between control group and treatment groups after 13 weeks of treatment or further 2 weeks post exposure in male and female rats ([Table 1](#T001){ref-type="table"}).

###### 

Absolute and relative kidney weight after 13-week exposure or 2-week recovery after the exposure to diet containing 0 (control group), 5,000, 10,000, 50,000 ppm of *Paecilomyces sinclairii* in rats

  ------------------ ------------------ -------------------------------- --------------- --------------- --------------- ------------- -------------
  Dose group (ppm)   13-Week exposure   2-Week recovery after exposure                                                                 
                                                                                                                                       
  0                  5000               10,000                           50,000          0               50,000                        
                                                                                                                                       
  Male               Right kidney       1.52 ± 0.24^a^                   1.51 ± 0.27     1.44 ± 0.15     1.44 ± 0.08     1.59 ± 0.16   1.53 ± 0.13
  (0.28 ± 0.03)^b^   (0.29 ± 0.04)      (0.28 ± 0.03)                    (0.29 ± 0.02)   (0.28 ± 0.04)   (0.29 ± 0.02)                 
  Left kidney        1.49 ± 0.25        1.49 ± 0.26                      1.42 ± 0.15     1.41 ± 0.09     1.59 ± 0.15     1.50 ± 0.09   
  (0.28 ± 0.03)      (0.28 ± 0.04)      (0.28 ± 0.03)                    (0.29 ± 0.02)   (0.28 ± 0.04)   (0.29 ± 0.02)                 
  Female             Right kidney       0.97 ± 0.11                      0.93 ± 0.12     0.87 ± 0.09     0.91 ± 0.10     0.94 ± 0.07   0.87 ± 0.13
  (0.32 ± 0.03)      (0.28 ± 0.03)      (0.29 ± 0.02)                    (0.31 ± 0.04)   (0.29 ± 0.03)   (0.28 ± 0.02)                 
  Left kidney        0.96 ± 0.12        0.90 ± 0.11                      0.86 ± 0.09     0.90 ± 0.10     1.94 ± 0.05     0.86 ± 0.14   
  (0.32 ± 0.03)      (0.27 ± 0.03)      (0.29 ± 0.02)                    (0.30 ± 0.03)   (0.29 ± 0.03)   (0.28 ± 0.02)                 
  ------------------ ------------------ -------------------------------- --------------- --------------- --------------- ------------- -------------

^a^Absolute kidney weight (g); ^b^Relative kidney weight (%); Data are mean ± SD (n = 10).

###### 

Summary of incidence and severity of rat kidney histopathological lesions after 13-week exposure or 2-week recovery after the exposure to diet containing 0 (control group), 5,000, 10,000, 50,000 ppm of *Paecilomyces sinclairii* in rats

  --------------------------- ------------------ -------------------------------- -------- ---- -------- ---- ---- ---- --- --- ---- ---- ---
  Dose group (ppm)            13-Week exposure   2-Week recovery after exposure                                                           
                                                                                                                                          
  0                           5000               10,000                           50,000   0    50,000                                    
                                                                                                                                          
  Sex                         M                  F                                M        F    M        F    M    F    M   F   M    F    
  Karyomegaly                 Minimal            0                                0        0    9        0    0    0    2   0   0    0    1
  Mild                        0                  0                                1        1    0        10   0    5    0   0   1    2    
  Moderate                    0                  0                                8        0    10       0    8    3    0   0   4    2    
  Marked                      0                  0                                0        0    0        0    2    0    0   0   0    0    
  Severity of karyomegaly\*   0                  0                                26       11   30       20   32   21   0   0   14   11   
  Tubular hypertrophy         0                  0                                8        8    10       10   5    9    0   0   5    5    
  Tubular dilatation          0                  0                                0        0    0        0    6    0    0   0   0    0    
  --------------------------- ------------------ -------------------------------- -------- ---- -------- ---- ---- ---- --- --- ---- ---- ---

Data represent number of animals showing the lesions among 10 rats of each dose group.

\*Severity of karyomegaly: Sum of incidence multiply by severity (0 = not observed, 1 = minimal, 2 = mild, 3 = moderate, 4 =marked).

M, male; F, female.

***Renal histopathological lesions.*** At the end of the administration period of 13 weeks, histopathological findings related to the treatment were elucidated in kidney tissues of male and female rats. Kidney cell karyomegaly and tubular cell hypertrophy were observed in almost animals at all doses of treatment with severity was increased with dose dependency. After 2 weeks of withdrawal, the incidence and severity of karyomegaly and tubular cell hypertrophy were decreased but still the pathological lesions were observed in 50% of animals treated. Male rats were affected more severely than female rats ([Table 2](#T002){ref-type="table"}).

***Serum biochemistry.*** No significant treatment-related changes were observed in the levels of BUN and serum creatinine after 13 weeks treatment or 2 weeks withdrawal in male and female rats (Data not shown).

![Changes of KIM-1, TIMP-1, osteopontin and cystatin C in kidney of SD rats at 13 weeks of exposure and 2 weeks of postexposure to the diet containing 0 (control group), 5000, 10000 and 50000 ppm *Paecilomyces sinclairii*. At the end of exposure and recovery period kidney was collected for analysis. The data are expressed as means ± SD for each dose group (n = 10). \* p \< 0.05 and \*\* p \< 0.01 between control and treatment group.](toxicr-28-179-g001){#F001}

***Kidney toxicity biomarkers.*** None of kidney damage biomarkers in serum of treatment groups were significantly different from control group both in male and female rats after 13 weeks of treatment or 2 weeks post exposure (data not shown).

However, the level of KIM-1, TIMP-1 and osteopontin in kidney and urine were significantly increased at all doses of treatment in males and at the highest dose in females after or during 13 weeks of exposure. The increment of osteopontin in kidney of both genders was not recovered at 2 weeks post-exposure. Cystatin C in kidney was significantly decreased at all doses of treatment in both male and female rats but urinary cystatin C was significantly increased at 2, 8 and 13 weeks of exposure and then became normal at 2 weeks post-exposure. The changes in kidney damage biomarkers were more remarkable in male than in female rats ([Fig. 1](#F001){ref-type="fig"} and [2](#F002){ref-type="fig"}).

![Change of urinary Kim-1, TIMP-1, osteopontin and cystatin C in SD rats at 2, 8 and 13 weeks of exposure and 2 weeks of post-exposure to diet containing 0 (control group), 5000, 10000 and 50000 ppm *Paecilomyces sinclairii*. During exposure and recovery period, 24-hour urine samples were collected for analysis. The data are expressed as means ± SD for each dose group (n = 5). \* p \< 0.05 and \*\* p \< 0.01 between control and treatment group.](toxicr-28-179-g002){#F002}

DISCUSSION
==========

*Paecilomyces sinclairii* and *Isaria sinclairii* are entomopathogenic fungi formed from larvae and pupae of cicada and silk worms, respectively. Recently, a technique of mass production of *Paecilomyces sinclairii* has been successfully developed by isolation of *Paecilomyces PS* from cicada larvae and then artificial infection and cultivation from silk worm larvae [@B016]; [@B028].

In the present study, toxicity of the fruiting body of *Paecilomyces sinclairii* was investigated in the viewpoint of kidney damage.

There have been several studies of the safety of PS; those are acute oral toxicity studies in rats and dogs, sub-acute oral toxicity study in rats and a series of genotoxicity studies [@B002]; [@B016], [@B003].

The LD~50~ of both fungi was above 5 g/kg bw in rats and dogs, which means that they are practically non toxic materials. *Isaria sinclairii*presented no evidences of genotoxicity in Ames' test, in vitro chromosome aberration assay and rodent micronucleus test. However, the treatment of feed containing above 1.25% *Isaria sinclarii*(equivalent to 1 g/kg bw/day) resulted in increased numbers of tubular epithelial cells showing karyomegaly and edematous change with dose dependency in both sexes; however serum biochemical indicators (BUN and creatinine) remained in normal ranges [@B004]; [@B001].

Systemic karyomegaly associated with chronic interstitial nephritis could be the result of the action of some antimitotic agent such as chemical toxins or virus infections [@B023]. Ochratoxin A, a well-known nephrotoxic mycotoxin produced by *Aspergillus ochraceus*, induced karyomegaly with alteration of the tubular tissue and abnormal mitosis together with apoptotic-like kidney cells [@B021]. Ochratoxin A suppresses protein synthesis via inhibition of RNA synthesis and also lowers glucose level by the inhibition of phosphoenolpyruvate carboxykinase, a key enzyme in gluconeogenesis [@B007].

In the present study, histopathological lesions of kidney cells; karyomegaly and tubular cell hypertrophy were elucidated with dose-dependency and not recovered at 2 weeks post exposure. The reasons of the histopathological lesions of kidney cells are not clear, but it can be assumed that tubular cell mitosis is interrupted and renal dysfunction may be produced by the complex of fruiting body of *Paecilomyces sinclairii* and silk worm larvae.

Renal function is routinely monitored by serum creatinine and BUN levels. However, these biochemical indicators often only show elevation when a significant level of kidney functions is damaged. Early detection and diagnosis of kidney injury is critical for the prevention of severe kidney damage and failure.

In recent years, a number of urinary proteins have been proposed as early and sensitive biomarkers of renal injury and indicators of the localization of kidney lesions. These new biomarkers are KIM-1, NGAL, clusterin, GST-α, osteopontin, TIMP-1 and cystatin C [@B006]; [@B013]; [@B020]; [@B005]; [@B009].

The goal of this study was to determine if these new biomarkers are able to detect kidney injury at early stages of nephropathy in rats following a dietary exposure to the powder of PS.

In the present study, a suite of novel nephrotoxicity biomarkers was investigated using a multiplex assay system. Among kidney damage biomarkers investigated, KIM-1 and cystatin C were sensitively influenced by the treatment.

KIM-1 was increased but cystatin C was decreased in kidney with dose-dependency; while these markers in urine samples were all increased in male and female rats during exposure period. Furthermore the increment of KIM-1 in kidney of male rats was not recovered at 2 weeks postexposure.

KIM-1 is a type 1 membrane protein having extracellular immunoglobulin and mucin domains [@B011]. It is increased dramatically in kidney tissues and urine after injury in proximal tubule epithelial cells in postischemic rodent kidney. KIM-1 is suggested as a sensitive biomarker early-detected when cells undergo regeneration under oxidative stress and inflammation [@B010]; [@B029]. When folic acid is treated, urinary KIM-1 is significantly increased despite no change in serum creatinine. Also, cisplatin, a well known nephrotoxicant, results in early increment of urinary KIM-1 and high expression in proximal tubule cells, which occurs before the increment of serum creatinine [@B011]. When hexachloro-1:3-butadiene (HCBD), a nephrotoxic solvent, was administered intraperitoneally to rats, KIM-1 was increased 4.4 times in the urine comparing control, while 69 times increment in kidney KIM-1 mRNA expression [@B029]. Our study also presented that urinary KIM-1 reached peak with 9 times increment after 8 weeks of treatment and when 5 times increment was found in urine, there was 30 times rise in kidney at 13 weeks of exposure.

Cystatin C is a nonglycosylated 13 kDA protein and an extracellular inhibitor of cysteine proteases. It is produced by all nucleated cells at a constant rate, which makes the level of it unaffected by muscle mass unlike creatinin [@B017]. It is reabsorbed at proximal tubule so the level in urine correlates inversely with glomerular filtration rate or tubular damage [@B030]; [@B022]. [@B031] presented that urinary cystatin C was detected highly in diabetic nephropathy, which was prior to histopathological changes. In our study, urinary cystatin C was higher at 2, 8 and 13 weeks of treatment and then recovered at 2 weeks post exposure. The ratio of decrement of cystatin C in kidney was almost similar to that of increment in male urine at 13 weeks of treatment. However, serum cystatin C was not changed comparing control. These results indicated that cystatin C is an early and sensitive biomarker for nephropathy and the complex of *Paecilomyces sinclairii* and silk worm larvae may induce proximal tubule damage or filtration dysfunction.

Of the other biomarkers examined in our study, kidney level of TIMP-1 was found to be higher in male rats at 13 weeks of treatment. Urinary osteopontin was higher at 2 weeks of treatment but recovered thereafter even at exposure time. TIMP-1 and osteopontin are all suggested as biomarkers for nephropathy. TIMP-1 and osteopontin are upregulated following ischemia or cellular regeneration, which reveals kidney epithelial cell damage.

In addition, we also observed more pronounced response in male than female rats both in the changes of levels of biomarkers and histopathological lesions. Female rodents were reported to resist to ischemic acute renal failure more effectively than male animals [@B032]. [@B024] provided that the estrogen shows protective roles in ischemic acute renal failure in females. Acute renal failure is defined as a sudden loss of kidney functions to excrete metabolic wastes, reabsorb electrolytes and maintain body fluid balance [@B026].

Overall, a panel of new urinary biomarkers has been used to detect kidney damage following dietary exposure to the powder of PS in rats. The results suggest that KIM-1, cystatin C, TIMP-1 and osteopontin may serve as a promising noninvasive urinary biomarkers for earlier detection and monitoring of renal injury associated with damaged kidney cell and filtration failure.

We also demonstrated that levels of urinary and kidney KIM-1 and cystatin C were the most sensitively changed by the treatment with histopathological lesions of kidney.

Our study reveals that PS exposed orally may induce kidney cell damage and filtration dysfunction with more sensitivity in male rats. The mechanism underlying the nephrotoxicity of PS is unclear. A possible explanation can be obtained by further study focusing nephropathy with mechanistic and specific biomarkers of kidney toxicity.
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